| Urethral Carcinoma studied in …STUDIED_INderived34 of 34show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Muscle Invasive Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03237780Phase 2 · active not recruiting Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942331Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04953104Phase 2 · active not recruiting ARID1A and/or KDM6A Mutation and CXCL13 Expression · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582475Phase 1 · active not recruiting Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122172Phase 2 · terminated Afatinib in Advanced Refractory Urothelial Cancer · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513952Phase 2 · completed Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397394Phase 2 · terminated Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02437370Phase 1 · completed Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478361Phase 2 · completed Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935347Phase 2 · withdrawn Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178241Phase 2 · completed Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01282463Phase 2 · completed Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01611662Phase 2 · terminated Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526486NA · completed Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer · condition mapped ONTOLOGY_EXACT · 34 trials mapped (15 active) | — | — | Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407485Phase 2 · completed VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112905Phase 2 · terminated Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00471536Phase 2 · completed Pazopanib in Treating Patients With Metastatic Urothelial Cancer · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004856Phase 2 · terminated Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021099Phase 2 · completed Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer · condition mapped ALIAS · 34 trials mapped (15 active) | — | — | Distal Urethral Carcinoma | 1 | Observed | clinicaltrials | graph → |